Search results
Better High-Yield Dividend Stock: Pfizer vs. Bristol Myers Squibb
Motley Fool via Yahoo Finance· 7 days agoAt present, the drugmaker sports 37 candidates in late-stage development, underscoring the strength...
UK Government Snubs GSK in Favor of Pfizer’s Rival RSV Shot
Bloomberg· 1 day agoHave a confidential tip for our reporters? GSK Plc has lost out to Pfizer Inc. on a contract to...
Pfizer (PFE) Exceeds Market Returns: Some Facts to Consider
Zacks via Yahoo Finance· 7 days agoPfizer (PFE) closed at $27.41 in the latest trading session, marking a +1.59% move from the prior...
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
Zacks via Yahoo Finance· 4 days agoPfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is...
Alnylam Stock Pops on Surprising Results From a Key Heart Disease Drug
Barrons.com· 22 hours agoAlnylam said that patients with a rare heart condition called ATTR amyloidosis...The reduction was...
Alnylam (ALNY) Stock Soars 30% on Heart Disease Drug Success
InvestorPlace· 22 hours agoHeart disease drugmaker Alnylam (NASDAQ:ALNY) stock rose sharply on the success of a Phase 3 study...
3 No-Brainer Stocks to Buy for Under $100 Right Now
Motley Fool via Yahoo Finance· 3 days agoManagement is looking for around $25 billion in additional annual revenue by 2030 from its business development deals. These acquisitions haven't...
The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly
Zacks via Yahoo Finance· 4 days agoIts revenues have jumped from $28.3 billion in 2021 to $34.1 billion in 2023. Conclusion While other...
Alnylam's drug cuts risk of death, heart issues in key study, shares jump
Reuters via Yahoo News· 1 day ago(Reuters) -Alnylam Pharmaceuticals said its drug vutrisiran reduced deaths and cardiovascular events by a third in a study involving patients with a rare heart disease, sending the ...
Novavax Seeks FDA Nod for Updated COVID-19 Vaccine - Novavax (NASDAQ:NVAX), Moderna (NASDAQ:MRNA)
Benzinga· 7 days agoSubject to necessary permissions from the FDA and CDC, Novavax intends to market this updated...